The DIA/FDA Oligonucleotide-based Therapeutic Conference will be held at the Grand Hyatt Washington at Washington Center, Washington, DC, September 9 – 11, 2015. This conference, the sixth in eight years, is jointly sponsored by DIA and the FDA, and provides a unique forum for dialogue between regulators and industry from CMC, Nonclinical, Clinical Pharmacology, and Clinical disciplines Speakers from industry and regulatory agencies will address the developmental advances, safety, and challenges in the field of oligonucleotide-based therapeutics, including antisense, siRNA, and microRNA therapies. Conference details are available here.